Explore 2 Growth

1 investments found
Other

Athera Biotechnologies

Athera is a clinical stage biopharmaceutical company focused on developing targeted anti-inflammatory biological drugs for treatment of cardiovascular disease.
Funded SEK 55,095,000
Target SEK 30,000,000
Capital Target SEK 60,000,000
Min. Raise SEK 30,000,000
Percent of Equity Offered 55%
Valuation of equity SEK 110000000
End Date 21 April 2019
2 Growth
View Investment